NasdaqCM - Delayed Quote • USD
Jasper Therapeutics, Inc. (JSPR)
At close: April 23 at 4:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CARLYLE GROUP, INC. Unknown | Purchase | Feb 8, 2024 | -- |
| EMSTER KURT VON Director | Sale | Apr 13, 2023 | 21,175 |
| FRENCH ANNA LOUISE Director | Sale | Apr 14, 2023 | 23,750 |
| LIS WILLIAM Director | Sale | Oct 13, 2023 | 53,521 |
| MAHAL JEETINDER SINGH Chief Operating Officer | Sale | Mar 12, 2024 | 25,009 |
| MARTELL RONALD A Chief Executive Officer | Stock Award(Grant) | Oct 12, 2022 | 506,250 |
| QIMING U.S. HEALTHCARE FUND II, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 27, 2023 | -- |
| ROCHE HOLDING, LTD., Beneficial Owner of more than 10% of a Class of Security | Sale | Jan 25, 2023 | -- |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 8, 2024 | -- |
| WIGGANS THOMAS G Director | Purchase | Nov 28, 2023 | 50,000 |
Related Tickers
CLDX Celldex Therapeutics, Inc.
37.77
-2.78%
TRML Tourmaline Bio, Inc.
15.09
-2.65%
APGE Apogee Therapeutics, Inc.
49.77
+2.32%
FDMT 4D Molecular Therapeutics, Inc.
24.81
-5.99%
IGMS IGM Biosciences, Inc.
7.70
+14.07%
ZURA Zura Bio Limited
3.4800
+5.14%
MRUS Merus N.V.
40.82
+0.91%
LPTX Leap Therapeutics, Inc.
3.2000
-0.31%
PEPG PepGen Inc.
11.72
+2.90%
SYRE Spyre Therapeutics, Inc.
34.25
+2.87%